Progress in the evaluation of modified vaccinia Ankara vaccine against mpox

被引:2
|
作者
Mazzotta, Valentina [1 ]
Matusali, Giulia [2 ]
Oliva, Alessandra [1 ]
Maggi, Fabrizio [2 ]
Antinori, Andrea [1 ]
机构
[1] Natl Inst Infect Dis Lazzaro Spallanzani IRCCS, Clin & Res Infect Dis Dept, I-00149 Rome, Italy
[2] Natl Inst Infect Dis Lazzaro Spallanzani IRCCS, Lab Virol, I-00149 Rome, Italy
来源
LANCET INFECTIOUS DISEASES | 2023年 / 23卷 / 11期
关键词
D O I
10.1016/S1473-3099(23)00369-9
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
引用
收藏
页码:1214 / 1215
页数:2
相关论文
共 50 条
  • [41] Modified vaccinia virus ankara (MVA) - development as recombinant vaccine and prospects for use in veterinary medicine
    Volz, Asisa
    Fux, Robert
    Langenmayer, Martin C.
    Sutter, Gerd
    BERLINER UND MUNCHENER TIERARZTLICHE WOCHENSCHRIFT, 2015, 128 (11-12): : 464 - 472
  • [42] Modified vaccinia virus Ankara protects macaques against respiratory challenge with monkeypox virus
    Stittelaar, KJ
    van Amerongen, G
    Kondova, I
    Kuiken, T
    van Lavieren, RF
    Pistoor, FHM
    Niesters, HGM
    van Doornum, G
    van der Zeijst, BAM
    Mateo, L
    Chaplin, PJ
    Osterhaus, ADME
    JOURNAL OF VIROLOGY, 2005, 79 (12) : 7845 - 7851
  • [43] Safety, immunogenicity and efficacy of modified vaccinia Ankara (MVA) against Dryvax® challenge in vaccinia-naive and vaccinia-immune individuals
    Parrino, Janie
    McCurdy, Lewis H.
    Larkin, Brenda D.
    Gordon, Ingelise J.
    Rucker, Steven E.
    Enama, Mary E.
    Koup, Richard A.
    Roederer, Mario
    Bailer, Robert T.
    Moodie, Zoe
    Gu, Lin
    Yan, Lihan
    Graham, Barney S.
    VACCINE, 2007, 25 (08) : 1513 - 1525
  • [44] Human Monkeypox Virus Infection in the Immediate Period After Receiving Modified Vaccinia Ankara Vaccine
    Hazra, Aniruddha
    Rusie, Laura
    Hedberg, Trevor
    Schneider, John A.
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2022, 328 (20): : 2064 - 2067
  • [45] Modified Vaccinia Virus Ankara: History, Value in Basic Research, and Current Perspectives for Vaccine Development
    Volz, A.
    Sutter, G.
    ADVANCES IN VIRUS RESEARCH, VOL 97, 2017, 97 : 187 - 243
  • [46] Multiantigenic Modified Vaccinia Virus Ankara Vaccine Vectors To Elicit Potent Humoral and Cellular Immune Reponses against Human Cytomegalovirus in Mice
    Chiuppesi, Flavia
    Nguyen, Jenny
    Park, Soojin
    Contreras, Heidi
    Kha, Mindy
    Meng, Zhuo
    Kaltcheva, Teodora
    Iniguez, Angelina
    Martinez, Joy
    La Rosa, Corinna
    Wussow, Felix
    Diamond, Don J.
    JOURNAL OF VIROLOGY, 2018, 92 (19)
  • [47] Vaccine strategies against Babesia bovis based on prime-boost immunizations in mice with modified vaccinia Ankara vector and recombinant proteins
    Jaramillo Ortiz, Jose Manuel
    Del Medico Zajac, Maria Paula
    Adriana Zanetti, Flavia
    Paula Molinari, Maria
    Jose Gravisaco, Maria
    Calamante, Gabriela
    Elizabeth Wilkowsky, Silvina
    VACCINE, 2014, 32 (36) : 4625 - 4632
  • [48] Cross-protective immunity against multiple influenza virus subtypes by a novel modified vaccinia Ankara (MVA) vectored vaccine in mice
    Brewoo, Joseph N.
    Powell, Tim D.
    Jones, Jeremy C.
    Gundlach, Nancy A.
    Young, Ginger R.
    Chu, Haiyan
    Das, Subash C.
    Partidos, Charalambos D.
    Stinchcomb, Dan T.
    Osorio, Jorge E.
    VACCINE, 2013, 31 (14) : 1848 - 1855
  • [49] A modified vaccinia Ankara vaccine expressing spike and nucleocapsid protects rhesus macaques against SARS-CoV-2 Delta infection
    Routhu, Nanda Kishore
    Gangadhara, Sailaja
    Lai, Lilin
    Davis-Gardner, Meredith E.
    Floyd, Katharine
    Shiferaw, Ayalnesh
    Bartsch, Yannic C.
    Fischinger, Stephanie
    Khoury, Georges
    Rahman, Sheikh Abdul
    Stampfer, Samuel David
    Schafer, Alexandra
    Jean, Sherrie M.
    Wallace, Chelsea
    Stammen, Rachelle L.
    Wood, Jennifer
    Joyce, Cohen
    Nagy, Tamas
    Parsons, Matthew S.
    Gralinski, Lisa
    Kozlowski, Pamela A.
    Alter, Galit
    Suthar, Mehul S.
    Amara, Rama Rao
    SCIENCE IMMUNOLOGY, 2022, 7 (72)
  • [50] Efficacy of the modified vaccinia Ankara virus vaccine and the replication-competent vaccine ACAM2000 in monkeypox prevention
    Kandeel, Mahmoud
    Morsy, Mohamed A.
    Abd El-Lateef, Hany M.
    Marzok, Mohamed
    El-Beltagi, Hossam S.
    Khodair, Khalid M. Al
    Albokhadaim, Ibrahim
    Venugopala, Katharigatta N.
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2023, 119